Literature DB >> 1533795

A suppressive lymphokine derived from Ts clone 13G2 is IL-10.

T Hisatsune1, Y Minai, K Nishisima, A Enomoto, K W Moore, T Yokota, K Arai, S Kaminogawa.   

Abstract

CD8+ suppressor T cell (Ts) clone 13G2 produced a soluble suppressive lymphokine, termed the T-cell growth inhibitory factor (TGIF), which suppressed the proliferation of type 1 helper T-cell (Th1) clone 3D20 cells. The specific activity of TGIF was concentrated approximately 66,000-fold (3.7 x 10(6) U/mg of protein) by sequential chromatography from the culture supernatant of 13G2 cells. The suppressive activity of the highly purified TGIF toward the proliferation of Th1 cells was neutralized by the anti-IL-10 monoclonal antibody, and was replaced by IL-10. We detected the IL-10 molecule in the highly purified TGIF by using immunoblotting with the anti-IL-10 antibody. A PCR study showed that mRNA of IL-10 was expressed in the 13G2 cells. From these results, we conclude that TGIF produced from CD8+ T-cell clone 13G2 was IL-10. The suppressive activity of the whole supernatant was also completely blocked by the anti-IL-10 antibody, suggesting that IL-10 could play an important role in immune suppression by Ts cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1533795

Source DB:  PubMed          Journal:  Lymphokine Cytokine Res        ISSN: 1056-5477


  5 in total

1.  Oral administration of antigen does not influence the proliferation and IFN-γ production of responsive CD8+ T cells but enables to establish T cell clones with different lymphokine production profile.

Authors:  K Nishijima; T Hisatsune; H Kato; M Kohyama; M Kakehi; S Hachimura; S Kaminogawa
Journal:  Cytotechnology       Date:  1997-11       Impact factor: 2.058

Review 2.  Herpesvirus-bacteria synergistic interaction in periodontitis.

Authors:  Casey Chen; Pinghui Feng; Jørgen Slots
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

3.  Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis.

Authors:  K E Balashov; S J Khoury; D A Hafler; H L Weiner
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

4.  Activation via TCR or IL-2 receptor of a CD8+ suppressor T cell clone: effect on IL-10 production and on proliferation of the suppressor T cell.

Authors:  Y Minai; T Hisatsune; K Nishijima; A Enomoto; S Kaminogawa
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

Review 5.  Description of CD8+ Regulatory T Lymphocytes and Their Specific Intervention in Graft-versus-Host and Infectious Diseases, Autoimmunity, and Cancer.

Authors:  Martha R Vieyra-Lobato; Jorge Vela-Ojeda; Laura Montiel-Cervantes; Rubén López-Santiago; Martha C Moreno-Lafont
Journal:  J Immunol Res       Date:  2018-08-05       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.